Company registration number 06481226 (England and Wales)
MALVERN MEDICAL GROUP LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
MALVERN MEDICAL GROUP LIMITED
COMPANY INFORMATION
Directors
Mr P A Broadbent
Mrs B K Broadbent
Mr P S Broadbent
Secretary
Mr P A Broadbent
Company number
06481226
Registered office
Unit 10
Northbrook Close
Barbourne
Worcester
Worcestershire
WR3 8BP
Accountants
Ormerod Rutter Limited
The Oakley
Kidderminster Road
Droitwich
Worcestershire
WR9 9AY
Bankers
Lloyds Bank Plc
4 The Cross
Worcester
Worcestershire
WR1 3PY
MALVERN MEDICAL GROUP LIMITED
CONTENTS
Page
Accountants' report
1
Balance sheet
2 - 3
Notes to the financial statements
4 - 7
MALVERN MEDICAL GROUP LIMITED
ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF MALVERN MEDICAL GROUP LIMITED FOR THE YEAR ENDED 31 MARCH 2026
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Malvern Medical Group Limited for the year ended 31 March 2026 which comprise, the balance sheet and the related notes from the company’s accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the b oard of d irectors of Malvern Medical Group Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Malvern Medical Group Limited and state those matters that we have agreed to state to the b oard of d irectors of Malvern Medical Group Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Malvern Medical Group Limited and its b oard of d irectors as a body, for our work or for this report.

It is your duty to ensure that Malvern Medical Group Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Malvern Medical Group Limited. You consider that Malvern Medical Group Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Malvern Medical Group Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory f inancial statements.

Ormerod Rutter Limited
2 July 2026
Chartered Accountants
The Oakley
Kidderminster Road
Droitwich
Worcestershire
WR9 9AY
MALVERN MEDICAL GROUP LIMITED
BALANCE SHEET
AS AT
31 MARCH 2026
31 March 2026
- 2 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
3
70,363
85,687
Investments
4
145,295
145,295
215,658
230,982
Current assets
Debtors
5
580,491
908,830
Cash at bank and in hand
1,124,617
636,566
1,705,108
1,545,396
Creditors: amounts falling due within one year
6
(92,047)
(96,928)
Net current assets
1,613,061
1,448,468
Total assets less current liabilities
1,828,719
1,679,450
Provisions for liabilities
7
(11,748)
(13,885)
Net assets
1,816,971
1,665,565
Capital and reserves
Called up share capital
8
100
100
Profit and loss reserves
1,816,871
1,665,465
Total equity
1,816,971
1,665,565

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

MALVERN MEDICAL GROUP LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2026
31 March 2026
- 3 -
The financial statements were approved by the board of directors and authorised for issue on 2 July 2026 and are signed on its behalf by:
Mr P A Broadbent
Director
Company registration number 06481226 (England and Wales)
MALVERN MEDICAL GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
- 4 -
1
Accounting policies
Company information

Malvern Medical Group Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 10, Northbrook Close, Barbourne, Worcester, Worcestershire, United Kingdom, WR3 8BP.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT.

Revenue from the provision of services is recognised by reference to the stage of completion, when the costs incurred and costs to complete can be estimated reliably.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and machinery
15% on reducing balance
Fixtures, fittings and equipment
25% on cost
Computer equipment
33% on cost
Motor vehicles
Enter depreciation rate via StatDB - cd78
1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

MALVERN MEDICAL GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 5 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.6
Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.7
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
3
3
MALVERN MEDICAL GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 6 -
3
Tangible fixed assets
Plant and machinery
Fixtures, fittings and equipment
Computer equipment
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 April 2025
145,318
81,498
1
40,591
267,408
Additions
-
0
3,648
-
0
-
0
3,648
At 31 March 2026
145,318
85,146
1
40,591
271,056
Depreciation and impairment
At 1 April 2025
95,970
73,066
-
0
12,685
181,721
Depreciation charged in the year
7,402
4,593
-
0
6,977
18,972
At 31 March 2026
103,372
77,659
-
0
19,662
200,693
Carrying amount
At 31 March 2026
41,946
7,487
1
20,929
70,363
At 31 March 2025
49,348
8,432
1
27,906
85,687
4
Fixed asset investments
2026
2025
£
£
Shares in group undertakings and participating interests
145,295
145,295
5
Debtors
2026
2025
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
580,491
612,374
Other debtors
-
0
296,456
580,491
908,830
6
Creditors: amounts falling due within one year
2026
2025
£
£
Taxation and social security
11,619
19,640
Other creditors
80,428
77,288
92,047
96,928
MALVERN MEDICAL GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 7 -
7
Provisions for liabilities
2026
2025
£
£
Deferred tax liabilities
11,748
13,885
8
Called up share capital
2026
2025
2026
2025
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A of £1 each
30
30
30
30
Ordinary of £1 each
30
30
30
30
Ordinary Deferred of £1 each
30
30
30
30
Ordinary Preferred of £1 each
10
10
10
10
100
100
100
100
9
Related party transactions

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions.

10
Directors' transactions

Advances or credits have been granted by the company to its directors as follows:

Description
% Rate
Opening balance
Amounts repaid
Closing balance
£
£
£
Loan account
-
296,456
(296,456)
-
296,456
(296,456)
-
11
Ultimate controlling party

The ultimate controlling party is Mr P S Broadbent and Mrs B K Broadbent.

2026-03-31 2025-04-01 false false false 02 July 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Mrs B K Broadbent Mr P S Broadbent Mr P S Broadbent Mr P A Broadbent 06481226 2025-04-01 2026-03-31 06481226 bus:CompanySecretaryDirector1 2025-04-01 2026-03-31 06481226 bus:Director1 2025-04-01 2026-03-31 06481226 bus:Director2 2025-04-01 2026-03-31 06481226 bus:CompanySecretary1 2025-04-01 2026-03-31 06481226 bus:Director3 2025-04-01 2026-03-31 06481226 bus:RegisteredOffice 2025-04-01 2026-03-31 06481226 bus:Agent1 2025-04-01 2026-03-31 06481226 2026-03-31 06481226 2025-03-31 06481226 core:PlantMachinery 2026-03-31 06481226 core:FurnitureFittings 2026-03-31 06481226 core:ComputerEquipment 2026-03-31 06481226 core:MotorVehicles 2026-03-31 06481226 core:PlantMachinery 2025-03-31 06481226 core:FurnitureFittings 2025-03-31 06481226 core:ComputerEquipment 2025-03-31 06481226 core:MotorVehicles 2025-03-31 06481226 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 06481226 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 06481226 core:CurrentFinancialInstruments 2026-03-31 06481226 core:CurrentFinancialInstruments 2025-03-31 06481226 core:ShareCapital 2026-03-31 06481226 core:ShareCapital 2025-03-31 06481226 core:RetainedEarningsAccumulatedLosses 2026-03-31 06481226 core:RetainedEarningsAccumulatedLosses 2025-03-31 06481226 core:ShareCapitalOrdinaryShareClass1 2026-03-31 06481226 core:ShareCapitalOrdinaryShareClass1 2025-03-31 06481226 core:ShareCapitalOrdinaryShares 2026-03-31 06481226 core:ShareCapitalOrdinaryShares 2025-03-31 06481226 core:PlantMachinery 2025-04-01 2026-03-31 06481226 core:FurnitureFittings 2025-04-01 2026-03-31 06481226 core:ComputerEquipment 2025-04-01 2026-03-31 06481226 core:MotorVehicles 2025-04-01 2026-03-31 06481226 2024-04-01 2025-03-31 06481226 core:PlantMachinery 2025-03-31 06481226 core:FurnitureFittings 2025-03-31 06481226 core:ComputerEquipment 2025-03-31 06481226 core:MotorVehicles 2025-03-31 06481226 2025-03-31 06481226 bus:OrdinaryShareClass1 2025-04-01 2026-03-31 06481226 bus:OrdinaryShareClass1 2026-03-31 06481226 bus:OrdinaryShareClass1 2025-03-31 06481226 bus:AllOrdinaryShares 2026-03-31 06481226 bus:AllOrdinaryShares 2025-03-31 06481226 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 06481226 bus:FRS102 2025-04-01 2026-03-31 06481226 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 06481226 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 06481226 bus:FullAccounts 2025-04-01 2026-03-31 xbrli:pure xbrli:shares iso4217:GBP